We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

73 hedge funds and large institutions have $735M invested in Sage Therapeutics in 2014 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 26 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 6

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

160% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 10

40% more funds holding

Funds holding: 52 → 73 (+21)

23% more capital invested

Capital invested by funds: $596M → $735M (+$140M)

Holders
73
Holders Change
+21
Holders Change %
+40.38%
% of All Funds
1.95%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
28
Increased
26
Reduced
10
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BFA
BlackRock Fund Advisors
California
+$11.9M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$7.09M
3
JP Morgan Chase
JP Morgan Chase
New York
+$4.45M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$4.03M
5
Stifel Financial
Stifel Financial
Missouri
+$3.74M

Top Sellers

1
DM
Deerfield Management
New York
-$7.01M
2
PA
Perceptive Advisors
New York
-$5.15M
3
O
OrbiMed
New York
-$4.66M
4
Millennium Management
Millennium Management
New York
-$2.52M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
26
Driehaus Capital Management
Illinois
$1.97M +$2.01M +53,864 New
UBS AM
27
UBS AM
Illinois
$1.8M +$436K +11,700 +31%
NI
28
Numeric Investors
Massachusetts
$1.79M +$1.83M +49,040 New
Alyeska Investment Group
29
Alyeska Investment Group
Illinois
$1.74M -$1.94M -52,159 -52%
EAM
30
Eventide Asset Management
Massachusetts
$1.47M – – –
Bank of New York Mellon
31
Bank of New York Mellon
New York
$1.45M +$408K +10,938 +38%
NLVP
32
New Leaf Venture Partners
New York
$1.29M +$1.32M +35,370 New
Geode Capital Management
33
Geode Capital Management
Massachusetts
$1.27M +$375K +10,057 +41%
Goldman Sachs
34
Goldman Sachs
New York
$1.25M -$898K -24,082 -41%
DIA
35
Denver Investment Advisors
Colorado
$1.18M +$1.2M +32,201 New
NFA
36
Nationwide Fund Advisors
Ohio
$883K +$706K +18,947 +365%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$844K +$84.6K +2,271 +12%
BIM
38
BlackRock Investment Management
Delaware
$683K +$44.8K +1,203 +7%
BG
39
BlackRock Group
United Kingdom
$679K +$11.2K +300 +2%
ProShare Advisors
40
ProShare Advisors
Maryland
$670K +$683K +18,312 New
Citigroup
41
Citigroup
New York
$647K +$651K +17,455 +8,684%
ARTA
42
A.R.T. Advisors
New York
$625K +$637K +17,089 New
Neuberger Berman Group
43
Neuberger Berman Group
New York
$530K +$540K +14,500 New
TCIM
44
TIAA CREF Investment Management
New York
$527K +$78.2K +2,099 +17%
Deutsche Bank
45
Deutsche Bank
Germany
$463K -$191K -5,123 -29%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$390K +$1.68K +45 +0.4%
CS
47
Credit Suisse
Switzerland
$383K +$391K +10,485 New
Charles Schwab
48
Charles Schwab
California
$293K +$298K +8,000 New
TA
49
Teachers Advisors
New York
$281K +$86.5K +2,321 +43%
BlackRock
50
BlackRock
New York
$261K +$8.91K +239 +3%
1
2
3 4

SAGE Hedge Fund Activity: Q4 2014 in Review

73 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q4 2014, worth a combined $735M — up 23% from $596M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new SAGE positions and 6 closed out — a net gain of 22 holders — while 26 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $11.9M. The largest seller was Deerfield Management, cutting an estimated $7.01M.

  • 73 institutional investors held Sage Therapeutics (SAGE) as of Q4 2014, up from 52 in Q3 2014.
  • Funds reported $735M of Sage Therapeutics stock for Q4 2014, up 23% quarter-over-quarter.
  • 28 funds opened new Sage Therapeutics positions in Q4 2014 and 6 closed out, a net change of +22 holders.
  • The largest Sage Therapeutics buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $11.9M added.
  • The largest Sage Therapeutics seller in Q4 2014 was Deerfield Management, an estimated $7.01M sold.

Based on aggregated 13F filings for Q4 2014.